CONMED Corporation (CNMD)
Cash ratio
| Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalents | US$ in thousands | 38,929 | 33,935 | 35,485 | 24,459 | 38,467 | 28,869 | 33,855 | 24,296 | 30,502 | 27,848 | 26,494 | 28,942 | 33,354 | 53,152 | 24,864 | 20,847 | 31,511 | 46,388 | 36,769 | 27,356 |
| Short-term investments | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total current liabilities | US$ in thousands | 314,699 | 294,838 | 283,148 | 278,130 | 282,311 | 266,412 | 291,404 | 310,729 | 376,319 | 353,169 | 320,686 | 296,552 | 208,579 | 201,093 | 187,597 | 196,646 | 183,192 | 198,458 | 182,155 | 190,201 |
| Cash ratio | 0.12 | 0.12 | 0.13 | 0.09 | 0.14 | 0.11 | 0.12 | 0.08 | 0.08 | 0.08 | 0.08 | 0.10 | 0.16 | 0.26 | 0.13 | 0.11 | 0.17 | 0.23 | 0.20 | 0.14 |
September 30, 2025 calculation
Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($38,929K
+ $—K)
÷ $314,699K
= 0.12
Peer comparison
Sep 30, 2025
Company name
Symbol
Cash ratio
CONMED Corporation
CNMD
0.12
Abbott Laboratories
ABT
0.53
Stryker Corporation
SYK
0.53